Antisense Oligodeoxynucleotides Targeting ATM Enhance Apoptosis in Laryngeal Cancer
Author Information
Author(s): Feng Jun, Zou Jian, Li Li, Zhao Yongsheng, Liu Shixi
Primary Institution: West China Hospital of Sichuan University
Hypothesis
Can antisense oligodeoxynucleotides (AS-ODNs) targeting ATM enhance the radiosensitivity and apoptosis of laryngeal squamous cell carcinoma cells?
Conclusion
The study found that AS-ODNs targeting ATM reduce its expression and enhance the apoptosis of hep-2 cells to radiation both in vitro and in vivo.
Supporting Evidence
- ATM mRNA and protein levels were significantly reduced in hep-2 cells treated with AS-ODNs.
- The survival fraction of cells treated with AS-ODNs was lower than that of untreated cells after radiation.
- The inhibition rate of tumors treated with AS-ODNs and radiation was significantly higher than with radiation alone.
- The apoptotic index was significantly higher in tumors treated with AS-ODNs combined with radiation.
Takeaway
Scientists used a special treatment to help cancer cells die more easily when exposed to radiation, which could help patients with throat cancer.
Methodology
The study involved using antisense oligodeoxynucleotides to reduce ATM expression in hep-2 cells, followed by radiation exposure and various assays to measure cell survival and apoptosis.
Potential Biases
Potential bias in the selection of cell lines and the experimental conditions may affect the generalizability of the results.
Limitations
The study was conducted in a controlled environment with specific cell lines and may not fully represent the complexity of human tumors.
Participant Demographics
Female BALB/c-nu/nu mice, aged 3-4 weeks, weighing 18-22 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website